Effectiveness of Second-Line Pembrolizumab Monotherapy for the Treatment of Nonsmall Cell Lung Cancer: A Retrospective-Single Institution Study of 52 Vietnamese Patients.
Background: Our aim was to demonstrate the efficacy and safety of pembrolizumab monotherapy as second-line treatment in Vietnamese nonsmall cell lung cancer (NSCLC) patients. Methods: We performed a single-center retrospective study of patients with advanced NSCLC who received pembrolizumab as secon...
| Publicado en: | Clinical Medicine Insights: Oncology pp. 1 - 12 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
8/7/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |